Main Menu Jump to Page


Retainer Agreement
info@rosenlegal.com

Ampio shareholders have an opportunity to recover their investment losses.

Click "Join this Class Action" above.

Attorneys

Ampio Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) resulting from allegations that Ampio may have issued materially misleading business information to the investing public.

If you purchased shares of Ampio and would like to join the action, please click "Join This Class Action," above.

Press Release

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Ampio Pharmaceuticals, Inc. – AMPE

New York, N.Y., August 8, 2018. Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ampio Pharmaceuticals, Inc. (NYSE: AMPE) resulting from allegations that Ampio may have issued materially misleading business information to the investing public.

On August 7, 2018, during aftermarket hours, Ampio filed a Form 8-K with the SEC providing a regulatory update on the FDA’s review of Ampion, including the AP-003-A and AP-003-C trials. Ampio disclosed that it met with the FDA in July 2018 and received a response letter thereto, which stated that “as a single trial[,] the AP-003-A study alone does not appear to provide sufficient evidence of effectiveness to support [the Biologics License Application].” The FDA further provided that “the FDA does not consider the AP-003-C trial to be an adequate and well-controlled clinical trial.” On this news, shares of Ampio’s stock fell sharply during intraday trading on August 8, 2018.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Ampio investors. If you purchased shares of Ampio please visit the firm’s website at http://www.rosenlegal.com/cases-1397.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or zhalper@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Zachary Halper, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      zhalper@rosenlegal.com
      www.rosenlegal.com